Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

NCT02620280

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Brustgesundheitzentrum Tirol, Univ. Frauenklinik Innsbruck Innsbruck, Austria
  • Universitätsklinik für Innere Medizin III, mit Hämatologie, internistischer Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum Salzburg, Austria
  • Klinikum Augsburg International Patient Service Augsburg, Germany
  • Frauenarzt-Zentrum-Zehlendorf Berlin, Germany
View all 41 locations
View Trial Details
Completed

Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)

NCT03752723

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Ajou Medical Center Suwon, Gyeonggi-do, South Korea
  • National Cancer Center Goyang-si, South Korea
  • Gachon University Gil Medical Center Incheon, South Korea
View Trial Details
Completed

Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

NCT02971761

Conditions
Androgen Receptor Positive, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • City of Hope Corona Corona, California, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope Mission Hills Mission Hills, California, United States
View Trial Details
Completed

Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer

NCT04596150

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Moores Cancer Center La Jolla, California, United States
  • Los Angeles Hematology Oncology Medical Los Angeles, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • UCLA David Geffen Santa Monica, California, United States
View all 42 locations
View Trial Details
Completed

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

NCT03219268

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +48 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 40 locations
View Trial Details
Completed

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

NCT03454451

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +78 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • City Of Hope Duarte, California, United States
  • UC San Francisco San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 27 locations
View Trial Details

Related conditions